Ndeye Fatou Ngom-Gueye
Overview
Explore the profile of Ndeye Fatou Ngom-Gueye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kabore N, Cournil A, Poda A, Ciaffi L, Binns-Roemer E, David V, et al.
Kidney Int Rep
. 2022 Mar;
7(3):483-493.
PMID: 35257061
Introduction: G1 and G2 alleles have been associated with kidney-related outcomes in people living with HIV (PLHIV) of Black African origin. No APOL1-related kidney risk data have yet been reported...
2.
Ndiaye A, Bakhoum M, Tall A, Ngom-Gueye N, Seck M, Gueye B, et al.
Pan Afr Med J
. 2017 Sep;
27:125.
PMID: 28904655
Introduction: The "potentially preventable hospitalizations (PPH)'' are hospital admissions that could have been avoided through effective primary care given at the appropriate time. Non-communicable diseases (NCDs), causes of PPH, are...
3.
Ka D, Manga N, Ngom-Gueye N, Ndiaga D, Diop M, Cisse-Diallo V, et al.
Pan Afr Med J
. 2017 Jul;
27:16.
PMID: 28748017
Introduction: The objective of this work is to evaluate the different factors associated with immunovirologic dissociation despite highly active and effective antiretroviral treatment. Methods: We conducted a retrospective, cohort, descriptive...
4.
Diouf A, Cournil A, Ba-Fall K, Ngom-Gueye N, Eymard-Duvernay S, Ndiaye I, et al.
ISRN AIDS
. 2013 Sep;
2012:621565.
PMID: 24052880
Cardiovascular risk factors in people on antiretroviral treatment (ART) are poorly documented in resource-constrained settings. A cross-sectional study was conducted in 2009 to assess prevalence of diabetes and hypertension in...
5.
Dieye T, Ndiaye B, Dieng A, Fall M, Brittain N, Britain N, et al.
PLoS One
. 2013 Jul;
8(6):e67177.
PMID: 23840618
Tuberculosis (TB) is a global public health problem exacerbated by the HIV epidemic. Here we evaluate a candidate TB vaccine, MVA85A, in a Phase I study in HIV-infected adults in...
6.
Thiam M, Diop-Ndiaye H, Kebe K, Vidal N, Diakhate-Lo R, Diouara A, et al.
J Virol Methods
. 2012 Dec;
188(1-2):97-103.
PMID: 23266258
The objective of this study was to investigate the performance of the ViroSeq HIV-1 Genotyping System v2.0 on HIV-1 non-B strains identified in Senegalese patients. The study involved 150 patients,...
7.
Thiam M, Diop-Ndiaye H, Diouf A, Vidal N, Ndiaye O, Ndiaye I, et al.
J Clin Microbiol
. 2012 Dec;
51(2):578-84.
PMID: 23241378
In this study, we investigated the prevalence of human immunodeficiency virus type 1 (HIV-1) drug resistance mutations and genetic variability among Senegalese patients undergoing highly active antiretroviral therapy (ART) in...
8.
Diop-Ndiaye H, Toure-Kane C, Leye N, Ngom-Gueye N, Montavon C, Peeters M, et al.
AIDS Res Hum Retroviruses
. 2010 Sep;
26(10):1133-8.
PMID: 20849302
To evaluate the presence of drug resistance mutations in antiretroviral-naive patients in Dakar (Senegal), cross-sectional studies were conducted since the circulation of ARVs in the country. Protease and RT genes...
9.
Etard J, Diouf A, De Beaudrap P, Akoi K, Ngom-Gueye N, Ndiaye I, et al.
Open AIDS J
. 2010 Feb;
3:63-70.
PMID: 20148061
Objectives: Estimate tuberculosis (TB) incidence among patients receiving HAART. Compare the dynamic of the CD4-cell count and viral load before notification of the TB with the dynamic among patients remaining...